Neurode

Country:
Australia
Founding year:
2021

Neurode develops a wearable, non-invasive headband designed to support management of ADHD symptoms without medication. The company’s device combines brain stimulation with monitoring to deliver short, daily intervention sessions. Its approach focuses on accessibility and ease of use, enabling therapy to be completed in approximately 20 minutes per day. Neurode positions its technology within applied neurotherapy and digital health contexts.

The technology delivers targeted stimulation intended to influence neural activity patterns associated with attention and executive function. Brain activity is tracked during use to inform session delivery and support consistency over time. By combining stimulation and monitoring within a single wearable, the system aims to provide structured, repeatable intervention without invasive procedures. The platform emphasizes simplicity and adherence rather than complex clinical setup.

Neurode targets individuals with ADHD seeking drug-free, at-home management options. The device is positioned outside traditional pharmacological treatment pathways, focusing on complementary support rather than replacement of clinical care. Its approach reflects growing interest in brief, non-invasive neuromodulation tools designed for everyday use.

Cognitive and Mental Health
Biomarkers
Wearable

Articles about

Neurode

No articles yet!